Tarilian Laser Technologies and ViCardio® Capture Audience at the IDTechEX Show 2018, Santa Clara, California, USA.
Tarilian Laser Technologies (TLT), developer of ViCardio®, the world’s first wearable, beat to beat, non-invasive, accurate and comfortable TLT blood pressure monitor, has returned from a very successful show and presentation at the IDTechEX Show (Santa Clara, California), November 14-15, 2018 – a technology show venued in Silicon Valley presenting the latest emerging technologies from around the world.
Since 1999 IDTechEx has provided independent market research, business intelligence and events on emerging technology in over 80 countries. The IDTechEX Show, Santa Clara, included eight concurrent conferences and a single exhibition covering sensors and wearable technology, 3D printing, electric vehicles, energy storage, graphene, Internet of Things, and printed electronics. The event showcased 270 exhibiting companies from 50 countries.
Stephen Schaefer, General Counsel, and Dr. David Pearce, Non-Executive Director, delivered an address during the “Wearables in Healthcare” track of the conference, on the TLT breakthrough technology for continuous, cuff-less, and beat to beat blood pressure monitoring, to a large audience that showed keen interest in the TLT technology during a lively question and answer period following the address. In addition, Mr. Schaefer and Dr. Pearce exhibited TLT’s technology and ViCardio® blood pressure monitoring product on Demonstration Street of the exhibit hall, drawing a continuous steam of technologists and business professionals interested in the TLT breakthrough technology.
Commenting on the strong response received at the IDTechEx Show, Dr. Pearce stated: “This is my second IDTechEx conference and it was as exhilarating as the first. It was nice to see the strong interest in our technology and the ViCardio® product. The event is extremely well organised, and as a returning company, we were treated like one of the family! The mix of delegates, speaker and exhibitors leads to great contacts, and thought-provoking discussions. TLT and ViCardio are grateful to be part of this community.”
Mr. Schaefer added, “I was impressed by the technological sophistication of the audience at the conference and visitors of our demonstration area in the exhibit hall. David and I really enjoyed the questions and interest shown in our breakthrough technology for haemodynamic monitoring.”
The ViCardio® device is currently being submitted for European CE mark approval and FDA clearance. The first thousand devices are anticipated to be available for online purchase in approximately early 2019, following CE marking clearance.
About Tarilian Laser Technologies Limited
Tarilian Laser Technologies Limited (TLT) is a Medtech Company based in Welwyn Garden City, Hertfordshire, UK (Head Office and Labs), as well as having its Vicardio® Commercial office in Leeds, UK and also its US operations office in Minneapolis, Minnesota, USA. TLT is also opening a new regulatory office in Singapore. Our main clinical centre is The Barts Heart Centre in London, Europe’s largest cardiovascular research centre.
Please see: www.tarilian.co.uk to directly access the 30-minute Bloomberg World-Wide Business Interview that summarises TLT and Vicardio®.
TLT is an advanced Medtech SME and is 13485(2016) registered with solid competencies in medical engineering, research & development, clinical trials, regulatory affairs and commercialisation. TLT has developed a novel optical platform based on its internal proprietary patented opto-electronic micro-sensor for full haemodynamic profiling including an ability to generate beat to beat blood pressure, compliance data, cardiac output and regional blood flow and blood pressure. A unique aspect of the TLT Sapphire sensor is that no energy enters the body at all – hence it is truly NON-invasive and also does not require any compression/cuff and or require any calibration in any manner. You simply apply the sensor on the body and it works instantly delivering continuous beat to beat haemodynamic data. The technology has already won many awards and TLT has continued with a number of additional break-throughs in sensor development- and now is planning a series of product launches from Early 2019, to begin the introduction of the technology into a number of international Medtech and consumer wearable markets.
About ViCardio Limited
ViCardio Limited was set up as a commercialisation company by Tarilian Laser Technologies Limited (TLT) in early 2018 with the mission to improve the diagnosis, monitoring and control of blood pressure in the community. The ViCardio® product is TLT’s first wearable blood pressure monitor, powered by TLT’s proprietary optical-electronic micro-motion sensor that allows blood pressure to be measured with each beat of the heart using a simple and elegant wrist-based wearable.
For more information please contact:
Dr Sandeep Shah, CEO of TLT and ViCardio:
Office: +44 (0) 1707 332 883
Laura Garcia, ViCardio Marketing Executive:
Office: +44 (0) 3303352277